Medicure Inc.

OTC: MCUJF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Winnipeg, MBCIK 0001133519Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 54

v0.1 · 5/100 weight · pillars only

↑ return on assets, listing tenure · ↓ filing timeliness, Piotroski F

Methodology →

Revenue TTM

$22.7M

Rev growth YoY (TTM)

+45.4%

Net income (FY)

-$758.5k

Employees

Market cap

$7.0M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$758.5k-1.0M CAD2024

Total assets$20.6M29.7M CAD2024

Liabilities$6.2M8.9M CAD2024

Revenue by segment

Filed disclosures · FY2022

By product

Aggrastat100%

By geography

Not disclosed.

The read

Medicure Inc. earned -$758.5k in FY2024 net income.

Peers · Healthcare

Galera Therapeutics, Inc.——Jasper Therapeutics, Inc.——BioCardia, Inc.29D BioCorRx Inc.44D

Key facts

CEOAlbert David Friesen

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersWinnipeg, MB

ExchangeOTC: MCUJF

Employees23

IPO date2004-02-19

Latest filings

6-K2026-05-21 6-K2026-05-21 6-K2026-05-21 6-K2026-04-24 20-F2026-04-24 6-K2026-04-23 6-K2025-11-19 6-K2025-11-19

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.